AMH Equity Ltd Takes Position in Health Catalyst, Inc. (NASDAQ:HCAT)

AMH Equity Ltd acquired a new stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 252,500 shares of the company's stock, valued at approximately $1,144,000. Health Catalyst accounts for approximately 1.7% of AMH Equity Ltd's investment portfolio, making the stock its 21st biggest holding. AMH Equity Ltd owned about 0.36% of Health Catalyst at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Light Asset Management LLC raised its position in shares of Health Catalyst by 22.0% during the 4th quarter. First Light Asset Management LLC now owns 5,241,121 shares of the company's stock valued at $37,055,000 after acquiring an additional 944,631 shares in the last quarter. Daventry Group LP grew its stake in Health Catalyst by 3.8% during the 4th quarter. Daventry Group LP now owns 2,509,480 shares of the company's stock worth $17,742,000 after buying an additional 91,878 shares during the last quarter. Nepsis Inc. lifted its stake in Health Catalyst by 2,072.1% in the first quarter. Nepsis Inc. now owns 2,090,812 shares of the company's stock valued at $9,471,000 after buying an additional 1,994,555 shares during the last quarter. Alyeska Investment Group L.P. boosted its stake in Health Catalyst by 74.4% during the 4th quarter. Alyeska Investment Group L.P. now owns 2,019,380 shares of the company's stock valued at $14,277,000 after purchasing an additional 861,150 shares during the period. Finally, Kennedy Capital Management LLC raised its holdings in shares of Health Catalyst by 42.7% during the fourth quarter. Kennedy Capital Management LLC now owns 1,891,000 shares of the company's stock valued at $13,369,000 after buying an additional 565,445 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company's stock.

Health Catalyst Stock Down 2.7%

NASDAQ:HCAT traded down $0.10 during trading hours on Friday, reaching $3.65. The company's stock had a trading volume of 450,571 shares, compared to its average volume of 607,803. Health Catalyst, Inc. has a one year low of $3.49 and a one year high of $9.24. The business's 50-day moving average is $3.89 and its 200-day moving average is $4.54. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.24 and a quick ratio of 1.24. The company has a market cap of $254.04 million, a price-to-earnings ratio of -3.17 and a beta of 1.51.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Evercore ISI reduced their price target on shares of Health Catalyst from $5.00 to $4.00 and set an "in-line" rating for the company in a research note on Wednesday, July 9th. Citigroup cut their target price on Health Catalyst from $7.00 to $6.50 and set a "buy" rating for the company in a research report on Friday, April 25th. Stifel Nicolaus increased their price target on Health Catalyst from $5.00 to $5.50 and gave the company a "hold" rating in a research note on Thursday, May 8th. BTIG Research lowered Health Catalyst from a "buy" rating to a "neutral" rating in a report on Tuesday, June 17th. Finally, Canaccord Genuity Group lowered their target price on Health Catalyst from $10.00 to $9.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $8.00.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.